Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1998-10-28
|
pubmed:abstractText |
Endometrium is one of the main target tissues of oestrogens. Although homozygous inactivation of oestrogen receptor-alpha leads to infertility in transgenic mice, oestrogen receptor-alpha is detected in endometrium of patients with unexplained infertility. Oestrogen receptor-alpha splicing variants and oestrogen receptor-beta have been studied in oestrogen target tissues, but their expression in endometrium throughout the menstrual cycle and in unexplained infertility is unknown. Using reverse transcription-polymerase chain reaction (RT-PCR), we studied the expression of oestrogen receptor-alpha splicing variants and oestrogen receptor-beta in uterine biopsies from 12 patients with endometriosis and 15 patients with unexplained infertility. A control group included 19 women who had had a previous pregnancy. Our study gave evidence of exon 2, 3, 4 or 7 deleted oestrogen receptor-alpha variants co-existing with the wild-type receptor. We did not find any exon 5 or 6-deleted variants. Exon 4 or 7-deleted variants were detected in all samples. Exon 2 or 3-deleted variants were detected at a similar frequency in fertile women (58 and 68% respectively), endometriotic patients (67 and 83% respectively) and infertile patients (73 and 80% respectively). During the follicular phase, there was a non-significant trend towards a lower frequency of exon-2 deleted variants in the fertile group when compared with the hypofertile group. Oestrogen receptor-beta was detected in all samples. Our preliminary study showed that altered expression of oestrogen receptor-alpha variants and oestrogen receptor-beta may not explain the hypofertility state.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1360-9947
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
641-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9701786-Alternative Splicing,
pubmed-meshheading:9701786-Animals,
pubmed-meshheading:9701786-Endometrium,
pubmed-meshheading:9701786-Estrogen Receptor alpha,
pubmed-meshheading:9701786-Estrogen Receptor beta,
pubmed-meshheading:9701786-Exons,
pubmed-meshheading:9701786-Female,
pubmed-meshheading:9701786-Humans,
pubmed-meshheading:9701786-Infertility, Female,
pubmed-meshheading:9701786-Mice,
pubmed-meshheading:9701786-Mice, Transgenic,
pubmed-meshheading:9701786-Polymerase Chain Reaction,
pubmed-meshheading:9701786-Pregnancy,
pubmed-meshheading:9701786-RNA, Messenger,
pubmed-meshheading:9701786-Receptors, Estrogen,
pubmed-meshheading:9701786-Sequence Analysis, DNA
|
pubmed:year |
1998
|
pubmed:articleTitle |
Expression of oestrogen receptor-alpha splicing variants and oestrogen receptor-beta in endometrium of infertile patients.
|
pubmed:affiliation |
Laboratoire de Biologie Cellulaire et Hormonale, CHRU Arnaud de Villeneuve, Montpellier, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|